We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+12.56%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.7B
AUM Growth
+$4.94B
(+10%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
26.8%
Holding
1,539
New
66
Increased
528
Reduced
500
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$157M |
| 2 |
Verizon
VZ
|
+$140M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
KLA
KLAC
|
+$115M |
| 5 |
Dell
DELL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XRTX
XORTX Therapeutics
XRTX
|
+$161M |
| 2 |
L3Harris
LHX
|
+$104M |
| 3 |
Voya Financial
VOYA
|
+$99.6M |
| 4 |
BCE
BCE
|
+$88.6M |
| 5 |
NVIDIA
NVDA
|
+$87.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.6% |
| 2 | Healthcare | 16.46% |
| 3 | Financials | 10.3% |
| 4 | Industrials | 9.81% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
ANI Pharmaceuticals
ANIP
$1.72B
| $1.57M | ﹤0.01% |
23,022
| – | – |
|
802
Southwest Airlines
LUV
$22B
| $1.56M | ﹤0.01% |
54,048
-2,657
| -5% | -$82.2K |
|
803
Bath & Body Works
BBWI
$3.76B
| $1.56M | ﹤0.01% |
31,797
+322
| +1% | +$14.5K |
|
804
Ovintiv
OVV
$17.2B
| $1.56M | ﹤0.01% |
30,518
-49,327
| -62% | -$2.25M |
|
805
Alamos Gold
AGI
$13.8B
| $1.53M | ﹤0.01% |
105,000
+45,614
| +77% | +$576K |
|
806
Fortrea Holdings
FTRE
$1.69B
| $1.5M | ﹤0.01% |
38,219
-15,871
| -29% | -$550K |
|
|
RNAM
807
DELISTED
Avidity Biosciences
RNAM
| $1.48M | ﹤0.01% |
60,000
| – | – |
|
808
Dynatrace
DT
$14.7B
| $1.47M | ﹤0.01% |
31,407
-52,165
| -62% | -$2.72M |
|
809
Virtu Financial
VIRT
$5.05B
| $1.45M | ﹤0.01% |
72,229
-26,206
| -27% | -$483K |
|
810
TechnipFMC
FTI
$30.1B
| $1.45M | ﹤0.01% |
58,000
| – | – |
|
811
Edgewise Therapeutics
EWTX
$4.69B
| $1.44M | ﹤0.01% |
80,000
| – | – |
|
812
Repligen
RGEN
$9.45B
| $1.42M | ﹤0.01% |
7,750
-284
| -4% | -$54.1K |
|
813
HEICO Corp
HEI
$51.9B
| $1.41M | ﹤0.01% |
7,341
+3,855
| +111% | +$715K |
|
814
Arcturus Therapeutics
ARCT
$223M
| $1.41M | ﹤0.01% |
43,889
| – | – |
|
815
Iovance Biotherapeutics
IOVA
$2.95B
| $1.4M | ﹤0.01% |
100,000
| – | – |
|
816
Vail Resorts
MTN
$5.18B
| $1.38M | ﹤0.01% |
6,370
-10,640
| -63% | -$2.37M |
|
817
Annaly Capital Management
NLY
$17.6B
| $1.38M | ﹤0.01% |
70,717
+791
| +1% | +$15.3K |
|
818
Insmed
INSM
$27.6B
| $1.36M | ﹤0.01% |
50,000
| – | – |
|
819
Vaxcyte
PCVX
$8.76B
| $1.36M | ﹤0.01% |
20,000
| – | – |
|
820
Clearway Energy Class C
CWEN
$7.02B
| $1.35M | ﹤0.01% |
60,669
-40,524
| -40% | -$953K |
|
821
Arcutis Biotherapeutics
ARQT
$3.25B
| $1.34M | ﹤0.01% |
140,000
| – | – |
|
822
DraftKings
DKNG
$12.6B
| $1.34M | ﹤0.01% |
28,825
+1,195
| +4% | +$48.6K |
|
|
NTST
823
NETSTREIT Corp
NTST
$2.09B
| $1.33M | ﹤0.01% |
75,155
+58,201
| +343% | +$1.03M |
|
824
Denali Therapeutics
DNLI
$3.97B
| $1.32M | ﹤0.01% |
64,210
| – | – |
|
|
DAY
825
DELISTED
Dayforce
DAY
| $1.3M | ﹤0.01% |
19,788
-400
| -2% | -$27.3K |
|
Similar funds
NAMI
DekaBank Deutsche Girozentrale's Q1 2024 Portfolio in Review
As of Q1 2024, DekaBank Deutsche Girozentrale held 1,539 positions worth $53.7B, up 10% from $48.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
DekaBank Deutsche Girozentrale's Q1 2024 filing shows 66 new, 528 increased, 500 reduced and 103 closed positions. Its largest new stake was Flutter Entertainment: 112,763 shares worth $22.5M. The largest sale was XORTX Therapeutics, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q1 2024 buy was Flutter Entertainment: 112,763 shares worth $22.5M.
- DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q1 2024, an estimated $157M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2024 reduction was Voya Financial, cutting an estimated $99.6M.
- DekaBank Deutsche Girozentrale fully exited XORTX Therapeutics in Q1 2024, selling an estimated $161M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 27% of its $53.7B portfolio in Q1 2024.
- DekaBank Deutsche Girozentrale opened 66 new positions and closed 103 in Q1 2024.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $53.7B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.